ZD Skin Solution
Start Your Project
ZD Skin Solution
Explore the skincare product opportunities, ingredient trends, SPF growth and compliance considerations shaping Europe and North America in 2026.
Editorial image: a product-development view of the transatlantic skincare opportunity.
The strongest product opportunities in Europe and North America are not coming from one isolated “hero ingredient.” They are coming from product systems that combine visible efficacy, daily comfort, credible evidence and a clear market-specific use case.
Five signals stand out from public data and market activity during the past six months:
The practical conclusion for emerging brands is clear: the next successful launch is more likely to be a focused, evidence-led product system than a generic serum built around a fashionable ingredient.
Europe and North America share a strong interest in efficacy, skin health and ingredient transparency, but they do not reward exactly the same product story.
European development is shaped by a mature dermocosmetic market, a strong pharmacy and specialist-retail culture, and a regulatory environment that requires disciplined documentation before launch. The European Commission continues to update the framework around restricted substances and cosmetic ingredients, including 2026 amendments under Regulation (EC) No 1223/2009. European Commission
For brands, this creates an opportunity for products that are:
Brands planning a European launch should also review the ZD Compliance Guide and Ingredient Library before finalising a formula, product claim or label direction.
Europe is not a single market. A product intended for Germany, France, the United Kingdom or Southern Europe may need different language, texture, packaging and channel strategies. However, the common opportunity is to develop credible, tolerable and well-documented products, rather than relying on exaggerated claims.
Product direction: a lightweight barrier-care system for sensitive and dehydrated skin.
North American brands are competing in a highly saturated but highly responsive market. Circana’s first-half 2026 data shows that consumers are still spending across both prestige and mass channels, while selectively prioritising products that communicate functional and emotional value. Circana
The strongest product stories tend to combine:
The US market also requires more careful classification and compliance planning. Under MoCRA, responsible persons have obligations related to serious adverse-event reporting, and facilities and products may fall within registration and listing requirements depending on the relevant exemptions. FDA
For brands looking for a faster route to market, ZD Private Label Skincare Solutions can be considered alongside a custom formulation route. The right choice depends on the desired level of differentiation, formula ownership, development time and target order volume.
Barrier care is moving from a specialist concern into a basic infrastructure layer for skincare. The opportunity is no longer limited to a rich repair cream. Brands are extending barrier positioning across cleansers, serums, moisturisers, masks and daily SPF.
The Skinfix expansion into all Ulta stores illustrates the commercial logic: a sensitive-skin brand used a hero moisturiser, a cleanser, a hypochlorous mist and a starter kit to create multiple entry points into the routine. Beauty Independent
European versions should emphasise tolerance, minimal irritation and responsible claims. North American versions can place more emphasis on visible comfort, dryness relief, clinical testing and routine simplification.
Possible ingredient systems include ceramides, cholesterol, fatty acids, panthenol, ectoin, beta-glucan, squalane, glycerin and selected peptides. The commercial value is not in listing every ingredient; it is in explaining why the system works together and for whom.
Sun care has become one of the clearest opportunities across both markets. Circana reported that prestige sun care in Europe reached €239.7 million in the 12 months ending March 2026, up 17% year on year, while facial sun care rose 26% in value. In the United States, total sun care grew 6%, and masstige SPF grew 23%. Circana
This suggests that new brands should not think only in terms of “another sunscreen.” The stronger opportunity is a facial skincare format that makes daily SPF easier to use.
Europe offers opportunities around elegant textures, sensitive skin, dermocosmetic trust and daily facial use. North America offers opportunities around masstige pricing, mineral formats, tinted products, hybrid skincare and strong visual demonstrations.
SPF development must be treated as a compliance-led project. The claim, filter system, testing plan, labelling and target market should be defined together at the start.
Product direction: daily facial SPF designed to behave like a skincare step.
The market is gradually moving away from a single “anti-wrinkle ingredient” narrative toward broader healthy-ageing systems. Recent launches show this across different price tiers.
IOPE’s US launch combined targeted products with retinol, vitamin C and PDRN collections, positioning treatment-inspired efficacy at home. Amorepacific M&S Formula’s Ultra Peptide collection combined multiple peptide technologies with ceramides, niacinamide, omega 3 and 6, hyaluronic acid and polyglutamic acid, at accessible prices. Marks & Spencer
In North America, Curology’s Agency relaunch used “skin longevity” and personalisation to expand beyond traditional anti-ageing language. Its non-prescription Skin Smoothing Booster contains seven peptides, including copper peptide. Beauty Independent
The opportunity is not to add as many peptides as possible. It is to create a coherent system with:
Product direction: a premium active system built around peptides, recovery and credible evidence.
PDRN has become one of the most visible active-ingredient stories in 2026. Sephora’s US merchandising pages show PDRN as a multi-format category that extends beyond serums into moisturisers, masks, toners, mists and eye care. This is a retail assortment signal, not a complete market-size measure, but it shows that the ingredient story is being converted into a broader routine. Sephora
Cosmoprof North America reporting also identified PDRN as one of the most prominent ingredient narratives among suppliers and buyers, while warning brands to verify documentation, claims and formulation performance before launch. Beauty Independent
For Europe, the strongest positioning is likely to be around skin recovery, hydration, comfort and evidence-backed cosmetic benefits, supported by careful ingredient documentation. For North America, the opportunity is stronger in premium active skincare, treatment-inspired routines and visible-result storytelling.
PDRN should not be used as a substitute for product strategy. The manufacturer and brand should clarify source, specification, stability, safety substantiation, permitted claims and consumer communication before finalising the concept.
Consumers want simpler routines, but simplification does not mean reducing every product to a vague “all-in-one” claim. The better opportunity is to combine two or three related benefits in one product while keeping the product’s primary job clear.
Examples include:
NIQ’s 2026 beauty outlook describes a market shaped by convenience, personalisation, transparency and products that genuinely work. NIQ Beauty Independent’s 2026 channel analysis also highlights the need for brands to connect discovery, education, retail and replenishment rather than relying on one channel alone. Beauty Independent
The commercial implication is important: a product should be designed for the complete customer journey, from search and social discovery to first use, repeat purchase and potential retail expansion.
This is also why product concepts should be connected to a real development route. A trend article should lead naturally to a bulk formulation consultation, a cosmetic ingredient discussion or a request for custom OEM/ODM development, rather than ending with a generic “learn more” link.
| Product direction | Europe | North America | Recommended priority |
|---|---|---|---|
| Barrier-repair serum or cream | Strong | Strong | High for both markets |
| Sensitive-skin starter routine | Very strong | Strong | High |
| Lightweight facial SPF | Very strong | Strong | High, with market-specific testing |
| Tinted mineral SPF | Selective | Strong | Medium to high |
| Multi-peptide firming serum | Strong | Very strong | High |
| PDRN treatment | Emerging/premium | Strong/premium | Medium to high |
| Body care treatment | Growing | Strong | Medium to high |
| Personalised skincare system | Selective | Stronger fit | Medium |
This ranking is a strategic prioritisation, not a forecast of sales. It combines public sell-out data, retailer assortment signals, brand activity, industry reporting and development feasibility. Platform signals should be validated against a brand’s target price, channel, customer and regulatory pathway before investment.
Target markets: Europe and North America Target consumer: Sensitive, dehydrated or over-exfoliated skin Format: Lightweight, fragrance-free gel-cream Ingredient direction: Ceramide complex, panthenol, ectoin, beta-glucan and squalane Positioning: Daily barrier support without a heavy finish Why now: Barrier care is moving into everyday routines and can support a cleanser-serum-moisturiser system.
Target markets: Europe and North America, with separate market compliance routes Target consumer: Skincare users who want daily protection in a comfortable facial format Format: Lightweight fluid or serum-emulsion Ingredient direction: UV filter system selected for target-market compliance, plus niacinamide, panthenol or antioxidant support Positioning: Daily facial protection designed to layer under makeup Why now: Facial SPF is growing as a year-round skincare category rather than a seasonal product.
Target market: North America first; adaptable for Europe Target consumer: Consumers seeking firming, hydration and smoother-looking skin without aggressive exfoliation Format: Fast-absorbing serum Ingredient direction: Peptide blend, niacinamide, ceramides and multi-weight hyaluronic acid Positioning: Clinically minded, accessible healthy-ageing skincare Why now: Recent US and UK launches show peptide systems moving from premium niche products into wider price tiers.
Target market: North America and premium European channels Target consumer: Ingredient-literate users seeking treatment-inspired recovery and hydration Format: Concentrated ampoule or serum Ingredient direction: Verified PDRN specification combined with soothing, hydrating and barrier-supporting ingredients Positioning: Premium recovery-focused cosmetic treatment Why now: PDRN has moved from a niche ingredient conversation into multi-format retail merchandising and trade-show innovation.
For an ingredient-led launch, brands can compare available actives and positioning directions in the ZD Cosmetic Ingredients Library before requesting samples.
The data suggests that product opportunity is increasingly connected to development readiness. Before requesting samples, a brand should define:
Public discussions among suppliers and founders show that flexible MOQ, formula ownership, compliance support and scale-up capability remain important sourcing questions. Alibaba’s 2026 B2B content also reports strong buyer interest in pimple patches, serums and face creams, but these platform figures should be read as Alibaba-specific buyer signals rather than total market demand. Alibaba.com
Start with one clearly defined skin problem and one supporting routine product. A fragrance-free barrier serum, gentle cleanser or daily moisturiser can create a credible entry point. Build the EU safety and claims pathway before finalising packaging language.
Prioritise a product with a demonstrable result and a strong content story. Multi-peptide firming, barrier repair, PDRN recovery and facial SPF are promising directions, but each requires different evidence and claims planning. Build the replenishment path across DTC, marketplace and specialty retail from the beginning.
Use a shared product platform with regional adaptations rather than one completely identical launch. The formula may be similar, but the claims, testing, texture, packaging, educational content and retail strategy may need to differ.
Ask the manufacturing partner to connect market insight with formula development. A useful development partner should be able to discuss:
The 2026 opportunity in Europe and North America is not simply to follow the latest ingredient. It is to turn a visible market signal into a product that is credible, comfortable, compliant and commercially repeatable.
The strongest starting points for new product development are:
Brands that make these decisions early—before formula, claims and packaging are locked—will have a better chance of building products that can move from online discovery to repeat purchase and retail expansion.
Interested in developing a skincare product for Europe or North America? Share your target market, product direction and preferred format with our team. We can help you evaluate suitable ingredient systems, formula options and the next steps for sampling.
ZD’s OEM and ODM skincare development service can support the path from market direction to formula brief, sampling and production planning. For brands that already have a defined product idea, the next step is to start a project with the ZD team and include the target market, product format, expected price position and preferred launch timing.
The clearest opportunities are barrier-care systems, daily facial SPF, peptide-led healthy-ageing products, carefully substantiated PDRN treatments and multi-functional skincare with one clear primary benefit. The best choice depends on the target market, price position, claims strategy and channel.
Not always. A shared product platform can be efficient, but the formula, claims, testing, packaging, texture and compliance pathway may need to be adapted for each market. SPF products require especially careful market-by-market planning.
Private label or ODM can shorten the path to market and reduce early development risk. Custom OEM is more suitable when the brand needs a distinctive formula, greater control or stronger long-term product ownership. A hybrid route can combine a proven base with targeted customisation.
Prepare the target country or region, primary product benefit, target consumer, product format, target price, preferred ingredients, claim direction, expected order volume and launch timing. This allows the development team to recommend a realistic formula and documentation pathway.
ZD can discuss private label, OEM and ODM routes, ingredient systems, formula formats, sampling and production planning for brands targeting international markets. The specific compliance pathway should be confirmed according to the final formula, claims and destination market.
Evidence limitation: Public sources do not provide a single, comparable six-month sell-out dataset covering all European countries, the United States and Canada across every channel. This report therefore triangulates sell-out releases, retailer assortment, brand launch announcements, industry reporting, regulatory sources and B2B platform signals. Platform and trade-media evidence indicates direction and commercial activity; it should not be interpreted as a complete market-size forecast.
